NCT02188758View on ClinicalTrials.gov

Biomarkers of Iron Homeostasis and Responses to Cystic Fibrosis Pulmonary Exacerbation (CFPE) Treatment

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

December 31, 2017

Study Completion Date

January 31, 2018

Conditions
Cystic Fibrosis
Interventions
OTHER

Adults - CFPE Treatment

Hospitalization for comprehensive treatment of CF pulmonary exacerbation, including intravenous (IV) antibiotics, nutritional assessment and support, airway clearance of mucus, use of inhaled mucolytic agents and bronchodilators, glycemic control with insulin, and psychosocial support.

Trial Locations (2)

04106

Maine Medical Center, South Portland

03756

Dartmouth-Hitchcock Medical Center, Lebanon

Sponsors

Collaborators (1)

MaineHealth
All Listed Sponsors
collaborator

MaineHealth

OTHER

lead

Dartmouth-Hitchcock Medical Center

OTHER

NCT02188758 - Biomarkers of Iron Homeostasis and Responses to Cystic Fibrosis Pulmonary Exacerbation (CFPE) Treatment | Biotech Hunter | Biotech Hunter